文献速递主动脉疾病

CT测量的胸肌减少症与TEVAR术后晚期死亡率相关

CT-Derived Pretreatment Thoracic Sarcopenia Is Associated with Late Mortality after Thoracic Endovascular Aortic Repair.
PubMed 文献 · Ann Vasc Surg · 2019-11-06

本研究回顾了217例接受胸主动脉腔内修复术(TEVAR)的患者,通过CT测量T12水平的胸肌面积定义胸肌减少症,并与L3水平的腰肌减少症比较。结果显示胸肌减少症与TEVAR术后2年和5年死亡率显著升高相关,而腰肌减少症无此关联。

要点

  • 胸肌减少症与TEVAR术后2年及5年死亡率升高相关。
  • 腰肌减少症与TEVAR术后任何时间点死亡率无关。
  • 胸肌减少症患者TEVAR相关不良事件发生率更高。

核心结论

  • CT测量的胸肌减少症(而非腰肌减少症)与TEVAR术后5年死亡率显著相关。

研究设计与样本

  • 前瞻性收集2009至2012年217例接受TEVAR的患者数据,其中200例有术前影像可测量胸肌减少症,186例同时评估腰肌减少症。

主要发现

  • 胸肌减少症患者2年死亡率为19% vs 8%(P=0.02),5年死亡率为31% vs 18%(P=0.03)。
  • 胸肌减少症患者年龄更大、BMI更低、女性更多、更多因动脉瘤治疗。
  • 胸肌减少症患者充血性心力衰竭、高血压、既往血管介入及TEVAR相关不良事件发生率更高。
  • 腰肌减少症与任何时间点死亡率增加无关。
  • 48个月随访期间肌肉质量下降的患者不良事件发生率未显著升高。

临床怎么用

  • 术前CT测量T12水平胸肌面积可帮助识别TEVAR术后高死亡风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty, characterized by physiologic depletion, predicts postoperative morbidity and mortality in vascular surgery patients. CT-derived sarcopenia is a valuable method for objectively staging frailty preoperatively. PURPOSE: With prior analyses primarily measuring psoas cross-sectional area on CT, we compared a method of measuring thoracic sarcopenia to existing techniques of lumbar sarcopenia and assessed the association with long-term survival and outcomes post-Thoracic Endovascular Aortic Repair (TEVAR). METHODS: Prospectively collected data of 217 patients undergoing TEVAR from 2009 to 2012 were reviewed. Thoracic sarcopenia was quantified by measuring total area of the rectus abdominis, latissimus dorsi, intercostal, erector spinae, and external and internal oblique muscles at the T12 vertebral level. Total psoas area at the L3 was used to measure lumbar sarcopenia. RESULTS: 200 patients had preoperative imaging enabling measurements of thoracic sarcopenia, 186 of these patients were also assessed for lumbar sarcopenia. Thoracic sarcopenic patients were older, had lower body mass indices, were more commonly female, and most commonly being treated for aneurysms. Thoracic sarcopenic patients had significantly higher rates of congestive heart failure, hypertension, prior vascular intervention, and TEVAR-related adverse events. Thoracic sarcopenia was associated with significantly higher mortality at 2 and 5 years post-TEVAR (2-year mortality: 19% vs 8%, P = 0.02; 5-year mortality: 31% vs 18%, P = 0.03). Lumbar sarcopenia was not associated with increased mortality at any time point. Patients whose muscle mass degraded over 48-month follow-up did not experience significantly higher rates of adverse events. CONCLUSIONS: CT-derived thoracic sarcopenia, but not lumbar sarcopenia, is significantly associated with 5-year mortality post-TEVAR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Olson SL, Panthofer AM, Harris DJ, et al. CT-Derived Pretreatment Thoracic Sarcopenia Is Associated with Late Mortality after Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2019. PMID: 31705993. doi:10.1016/j.avsg.2019.10.089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。